Grønbæk, J K, Wibroe, M, Toescu, S, Frič, R, Thomsen, B L, Møller, L N, Grillner, P, Gustavsson, B, Mallucci, C, Aquilina, K, Fellows, G A, Molinari, E, Hjort, M A, Westerholm-Ormio, M, Kiudeliene, R, Mudra, K, Hauser, P, van Baarsen, K, Hoving, E, Zipfel, J, Nysom, K, Schmiegelow, K, Sehested, A, Juhler, M, Mathiasen, R & CMS study group 2021, ' Postoperative speech impairment and surgical approach to posterior fossa tumours in children : a prospective European multicentre cohort study ', The Lancet Child & Adolecent Health, vol. 5, no. 11, pp. 814-824 . https://doi.org/10.1016/S2352-4642(21)00274-1
RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5